RxDoctor Payments Data

Brianne Smith, DO

Family Medicine · Corvallis, ORNPI 1235666538

Payments from drug & device makers

$1,235in general payments, 2019–2025

Across 59 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi Pasteur Inc.$187
  • AbbVie$162
  • Pfizer$159
  • GSK$124
  • Novo Nordisk$113
  • Lilly USA, LLC$99
  • plus $390 from 14 others

What the payments were for

  • Food & beverage$1,235100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,235 in reported general payments places this provider in the 85th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$50,257
Medicare patients
126
Services billed
747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide32$33,936
TrulicityDulaglutide20$25,224
OzempicSemaglutide19$17,303
Estradiol26$4,186
Bupropion XlBupropion Hcl28$1,995
Levothyroxine Sodium132$1,617
Estradiol (Twice Weekly)Estradiol13$1,156
Atorvastatin Calcium121$1,060
ProgesteroneProgesterone, Micronized21$879
Armour ThyroidThyroid,pork12$793
Simvastatin43$739
Metoprolol Succinate53$731
Escitalopram Oxalate47$702
Lisinopril96$624
Alendronate Sodium24$436

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$99$59,16052 claims
Novo NordiskOzempic$113$17,30319 claims
AbbVieArmour Thyroid$162$79312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Corvallis

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →